Education
About Us
Working with TipRanks
Follow Us
Cybin (TSE:CYBN)
NEO-L:CYBN
CYBN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.14 - C$0.14
Previous CloseN/A
Volume13.54K
Average Volume (3M)0.00
Market Cap
$1.97M
Enterprise ValueN/A
Total Cash (Recent Filing)$136.29M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.46
Shares Outstanding23,023,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$128.34Price Target Upside91568.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Clinical TrialsCYB003's 71% remission rate at 12 months following two 16 mg doses, coupled with its FDA Breakthrough Therapy Designation, underscore meaningful registration potential.
Financial ResourcesThe recent announcement of a US$500 million convertible debenture facility—with US$50 million now funded—provides additional capital flexibility and extends runway beyond 2026.
Strategic PartnershipsCybin has expanded its partnership with Thermo Fisher Scientific to include U.S.-based manufacturing of both CYB003 drug substance and capsules, supporting Phase 3 supply and future commercial scale-up.
Bears Say
Market ReactionThe trial achieved statistical significance on the primary endpoint, but CMPS stock reacted negatively and since this was a bellwether event for psychedelic stocks, the group, including Cybin, also traded down.
Price Target AdjustmentThe price target was adjusted from $73 to $70.
Cybin News
CYBN FAQ
What was Cybin’s price range in the past 12 months?
Cybin lowest stock price was C$0.14 and its highest was C$0.14 in the past 12 months.
What is Cybin’s market cap?
Cybin’s market cap is $1.97M.
When is Cybin’s upcoming earnings report date?
Cybin’s upcoming earnings report date is Aug 07, 2025 which is in 4 days.
How were Cybin’s earnings last quarter?
Cybin released its earnings results on Jul 01, 2025. The company reported -C$1.46 earnings per share for the quarter, missing the consensus estimate of -C$1.304 by -C$0.156.
Is Cybin overvalued?
According to Wall Street analysts Cybin’s price is currently Undervalued.
Does Cybin pay dividends?
Cybin does not currently pay dividends.
What is Cybin’s EPS estimate?
Cybin’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cybin have?
Cybin has 23,023,630 shares outstanding.
What happened to Cybin’s price movement after its last earnings report?
Cybin reported an EPS of -C$1.46 in its last earnings report, missing expectations of -C$1.304. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cybin?
Currently, no hedge funds are holding shares in TSE:CYBN
Company Description
Cybin
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
CYBN Stock 12 Month Forecast
Average Price Target
C$128.34
▲(91568.10%Upside)
Technical Analysis
Restart Life Sciences
―
Waverley Pharma
―
MYND Life Sciences
―
Awakn Life Sciences
―
Doseology Sciences
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.14% Other Institutional Investors
98.83% Public Companies and Individual Investors
Options Prices
Currently, No data available
---